Furthermore, we provide new insights and theoretical foundations for diseases targeting CD4<sup>+</sup>T cell subsets aging as a treatment focus, offering novel approaches for therapy, especially in infections, cancers, autoimmune diseases, and other diseases in the elderly. This evidence concerns the gene CD4 and cancer.